Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity | Patent Publication Number 20120289528
US 20120289528 A1Patent NumberUS 09061029 B2
Application Number13509626
Filled DateNov 17, 2010
Priority DateNov 17, 2009
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.